XML 41 R18.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment Reporting
 9 Months Ended
Sep. 30, 2015
Segment Reporting [Abstract]  
SEGMENT REPORTING
SEGMENT REPORTING

We have three reportable segments comprised of Cardiovascular, Rhythm Management, and MedSurg. Our reportable segments represent an aggregate of operating segments. Each of our reportable segments generates revenues from the sale of medical devices. We measure and evaluate our reportable segments based on segment net sales and operating income, excluding the impact of changes in foreign currency and sales from divested businesses. Sales generated from reportable segments and divested businesses, as well as operating results of reportable segments, are based on internally-derived standard currency exchange rates, which may differ from year to year, and do not include intersegment profits. We restate segment information for the prior period based on our internally-derived standard currency exchange rates used for the current period in order to remove the impact of foreign currency exchange fluctuation. We exclude from segment operating income certain corporate-related expenses and certain charges or credits that our chief operating decision maker considers to be non-recurring and/or non-operational, such as amounts related to intangible asset impairment charges; acquisition-, divestiture-, restructuring- and litigation-related charges and credits; pension termination charges; and amortization expense. Although we exclude these amounts from segment operating income, they are included in reported consolidated operating income (loss) and are included in the reconciliation below.
A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying unaudited condensed consolidated statements of operations is as follows:
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions)
 
2015
 
2014
 
2015
 
2014
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
Interventional Cardiology
 
$
551

 
$
514

 
$
1,659

 
$
1,543

Peripheral Interventions
 
246

 
217

 
723

 
631

Cardiovascular
 
797

 
731

 
2,382

 
2,174

 
 
 
 
 
 
 
 
 
Cardiac Rhythm Management
 
483

 
482

 
1,456

 
1,441

Electrophysiology
 
61

 
54

 
182

 
167

Rhythm Management
 
544

 
536

 
1,638

 
1,608

 
 
 
 
 
 
 
 
 
Endoscopy
 
362

 
340

 
1,042

 
990

Urology and Pelvic Health
 
207

 
138

 
479

 
397

Neuromodulation
 
128

 
115

 
369

 
338

MedSurg
 
697

 
593

 
1,890

 
1,725

Net sales allocated to reportable segments
 
2,038

 
1,860

 
5,910

 
5,507

Sales generated from divested businesses
 
—

 
1

 
—

 
4

Impact of foreign currency fluctuations
 
(150
)
 
(15
)
 
(411
)
 
(18
)
 
 
$
1,888

 
$
1,846

 
$
5,499

 
$
5,493

 
 
 
 
 
 
 
 
 
Income (loss) before income taxes
 
 
 
 
 
 
 
 
Cardiovascular
 
$
249

 
$
201

 
$
732

 
$
565

Rhythm Management
 
97

 
76

 
252

 
209

MedSurg
 
235

 
192

 
590

 
535

Operating income allocated to reportable segments
 
581

 
469

 
1,574

 
1,309

Corporate expenses and currency exchange
 
(145
)
 
(90
)
 
(334
)
 
(205
)
Intangible asset impairment charges; pension termination charges; acquisition-, divestiture-, restructuring-, and litigation-related net charges and credits
 
(604
)
 
(206
)
 
(935
)
 
(586
)
Amortization expense
 
(131
)
 
(109
)
 
(361
)
 
(327
)
Operating income (loss)
 
(299
)
 
64

 
(56
)
 
191

Other expense, net
 
(68
)
 
(61
)
 
(256
)
 
(146
)
Income (loss) before income taxes
 
$
(367
)
 
$
3

 
$
(312
)
 
$
45